Effect of angiotensin converting enzyme inhibitor on plasma von Willebrand factor level in patients with coronary artery disease.
Hojo
Y
Y
Ikeda
U
U
Shimada
K
K
D000328:Adult; D000368:Aged; D000804:Angiotensin II / Q000502:physiology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000097:blood*; D004656:Enalapril / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014841:von Willebrand Factor / Q000378:metabolism*
D000806:Angiotensin-Converting Enzyme Inhibitors; D014841:von Willebrand Factor; D000804:Angiotensin II; D004656:Enalapril